MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.675
-0.002 (-0.33%)
Oct 10, 2024, 11:50 AM EDT - Market open

MiNK Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
9.313.3719.6438.892.690.3
Cash & Short-Term Investments
9.313.3719.6438.892.690.3
Cash Growth
-12.32%-82.85%-49.51%1345.06%799.94%-
Other Receivables
----0.250.53
Receivables
----0.250.53
Prepaid Expenses
0.10.050.300.490.09
Other Current Assets
0.060.180.470.740.660.01
Total Current Assets
9.473.620.439.634.10.92
Property, Plant & Equipment
0.850.951.070.610.460.39
Total Assets
10.324.5521.4740.244.561.31
Accounts Payable
3.23.915.8233.142.46
Accrued Expenses
4.635.044.241.761.862.6
Current Unearned Revenue
-----0.19
Other Current Liabilities
2.322.452.6211.719.222.17
Total Current Liabilities
10.1511.412.6816.4714.227.42
Long-Term Debt
4.41---43.8226.79
Other Long-Term Liabilities
12.3511.219.19-0.383.43
Total Liabilities
26.922.6121.8716.4758.4337.64
Common Stock
000000
Additional Paid-In Capital
123.95115.77110.83107.350.380.29
Retained Earnings
-139.91-133.4-110.94-82.95-52.74-36.5
Comprensive Income & Other
-0.61-0.43-0.29-0.63-1.52-0.13
Shareholders' Equity
-16.58-18.06-0.423.78-53.87-36.33
Total Liabilities & Equity
10.324.5521.4740.244.561.31
Total Debt
4.41---43.8226.79
Net Cash (Debt)
4.913.3719.6438.89-41.13-26.49
Net Cash Growth
-53.80%-82.85%-49.51%---
Net Cash Per Share
0.140.100.581.49-1.71-1.10
Filing Date Shares Outstanding
39.5434.733.9133.5624.1824.18
Total Common Shares Outstanding
39.4534.633.8633.4824.1824.06
Working Capital
-0.67-7.87.7223.17-10.13-6.5
Book Value Per Share
-0.42-0.52-0.010.71-2.23-1.51
Tangible Book Value
-16.58-18.06-0.423.78-53.87-36.33
Tangible Book Value Per Share
-0.42-0.52-0.010.71-2.23-1.51
Machinery
1.261.451.350.780.560.43
Source: S&P Capital IQ. Standard template. Financial Sources.